Molidustat was well tolerated for up to 36 months and appears to be an effective alternative to darbepoetin and epoetin in the long-term management of anemia associated with CKD.
No takes yet. Share an insight, caveat, or question.
Akizawa et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: